PACGOLD LIMITED — Director's Dealing 2023

Nov 21, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	PACGOLD LIMITED
ABN	30 636 421 782

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	ANTHONY WILLIAM SCHRECK
Date of last notice	21 November 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	The registered holders are: Anthony Schreck & Margaret Schreck < AW & ML Schreck S/F A/C> Mr Schreck is a trustee and beneficiary of the superannuation fund.
Date of change	22 November 2023
No. of securities held prior to change	Anthony Schreck (DIRECT): 860,000 fully paid ordinary shares. Anthony Schreck & Margaret Schreck < AW & ML Schreck S/F A/C>: 450,000 unlisted options exercisable at $0.36 each on or before 5 July 2025. 450,000 unlisted options exercisable at $0.42 each on or before 5 July 2027. 1,200,000 unlisted options exercisable at $0.75 each on or before 30 April 2025.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	(a) Ordinary shares (b) Options
Number acquired	(a) 105,263 ordinary shares (b) 52,632 options
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	(a) $0.19 per share (b) nil
No. of securities held after change	Anthony Schreck (DIRECT): 860,000 fully paid ordinary shares. Anthony Schreck & Margaret Schreck < AW & ML Schreck S/F A/C>: 105,263 fully paid ordinary shares 52,632 listed options exercisable at $0.19 each on or before 30 September 2026. 450,000 unlisted options exercisable at $0.36 each on or before 5 July 2025. 450,000 unlisted options exercisable at $0.42 each on or before 5 July 2027. 1,200,000 unlisted options exercisable at $0.75 each on or before 30 April 2025.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	Issue of shares and options following shareholder approval at the AGM on 20/11/2023.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

e disclosed in thispart.
Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

art 3– +Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No.
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3